Brind.

Plus Therapeutics is participating in a conference hosted by H.C. Wainwright, where Sean Lee serves as VP of Equity Research and Marc H. Hedrick is President and CEO.

1 report, 1 independent Updated Sep 3
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Plus Therapeutics is participating in a conference hosted by H.C. Wainwright, where Sean Lee serves as VP of Equity Research and Marc H. Hedrick is President and CEO.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • GlobeNewswirePlus Therapeutics to Participate in Fireside Chat at the H.C. Wainwright 27th Annual Global Investment Conference HOUSTON, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (“